HUTCHMED (China) Limited (LSE: HCM) Stock Analysis & Fundamentals

HCMHUTCHMED (China) Limited

LSE · GB · Healthcare · Drug Manufacturers - Specialty & Generic · hutch-med.com

182.00GBP0.00%Mkt Cap: 2.03B $P/E: 182.00Today

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and …

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap2.03B $

Enterprise Value402.68M $

Revenue (TTM)704.31M $

Gross Profit272.12M $

Net Income (TTM)586.04M $

Revenue/Share0.8170 USD

Last Price182.00 GBP

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees1.8K

CountryGB

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)182.00

P/E (Forward)48.63

PEG—

EV/EBITDA-15.30

EV/Revenue0.57

P/S2.88

P/B1.70

EPS (TTM)0.01

EPS (Forward)0.04

52W Range

181.504% of range195.00

52W High195.00 GBP

52W Low181.50 GBP

Profitability

Gross Margin38.68%

Oper. Margin0.31%

EBITDA Margin-3.74%

Profit Margin83.30%

ROE36.91%

ROA26.06%

Growth

Revenue Growth0.20%

Earnings Growth-96.50%

Cash Flow & Leverage

Operating CF-82.93M $

CapEx (TTM)30.97M $

FCF Margin-3.44%

FCF Yield-1.19%

Net Debt-1.64B $

Net Debt/EBITDA62.49

Balance Sheet

Debt/Equity0.08

Current Ratio5.64

Quick Ratio5.45

Book Value/Sh1.072 GBP

Cash/Share1.584 GBP

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 GBP

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split10:1

Split DateMay 30, 2019

Analyst Consensus

Rating1.8 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)325.52 GBP

Upside (mean)+78.9%

Target Range172.65 GBP – 515.94 GBP

GBP172.65+78.9% to meanGBP515.94

# Analysts7

Ownership

Shares Out.869.07M

Float522.94M

Insiders38.80%

Institutions19.44%

Technical

SMA 50171.53 (+6.1%)

SMA 200198.34 (-8.2%)

Beta0.44

S&P 52W Chg18.16%

Avg Vol (30d)47.46K

Avg Vol (10d)45.43K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—